Companies

Forte Biosciences

Mentioned in 2 analyzed podcast episodes across 2 shows

Episode Mentions

Pharma and BioTech Daily

Pharma and BioTech Daily · Jul 28, 2026

AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily

Acquired by Argenix; developing phase 2 vitiligo drug

Antibody-Drug Conjugates (ADCs) in OncologyNon-Stimulant ADHD TherapeuticsDuchenne Muscular Dystrophy (DMD) Treatments
View Analysis
Stock Movers

Stock Movers · Jul 10, 2026

Weekly Roundup: Meta's Big Week, Paramount Skydance Mixed, Forte Biosciences Soars

Surged 110% on positive early-stage clinical data for vitiligo drug; best week since 2024

Meta AI Competitive PositioningLarge Language Model CompetitionMedia Merger Debt Management
View Analysis